nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—CYP1A2—Imiquimod—skin cancer	0.0781	0.107	CbGbCtD
Carbamazepine—CYP2C8—Vismodegib—skin cancer	0.07	0.0959	CbGbCtD
Carbamazepine—CYP2C19—Vismodegib—skin cancer	0.0587	0.0804	CbGbCtD
Carbamazepine—CYP2C9—Vismodegib—skin cancer	0.0488	0.0669	CbGbCtD
Carbamazepine—ABCB1—Vismodegib—skin cancer	0.0474	0.0649	CbGbCtD
Carbamazepine—CYP1A2—Vemurafenib—skin cancer	0.0428	0.0587	CbGbCtD
Carbamazepine—CYP3A4—Temozolomide—skin cancer	0.0409	0.0561	CbGbCtD
Carbamazepine—CYP3A4—Imiquimod—skin cancer	0.0409	0.0561	CbGbCtD
Carbamazepine—ABCC2—Docetaxel—skin cancer	0.0394	0.054	CbGbCtD
Carbamazepine—CYP1A2—Dacarbazine—skin cancer	0.0328	0.045	CbGbCtD
Carbamazepine—CYP3A4—Vismodegib—skin cancer	0.0284	0.0389	CbGbCtD
Carbamazepine—CYP3A7—Docetaxel—skin cancer	0.0263	0.036	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0263	0.036	CbGbCtD
Carbamazepine—ABCB1—Dactinomycin—skin cancer	0.0249	0.0341	CbGbCtD
Carbamazepine—CYP2C8—Fluorouracil—skin cancer	0.0248	0.034	CbGbCtD
Carbamazepine—CYP3A4—Vemurafenib—skin cancer	0.0224	0.0307	CbGbCtD
Carbamazepine—CYP3A5—Docetaxel—skin cancer	0.0197	0.027	CbGbCtD
Carbamazepine—CYP1A2—Fluorouracil—skin cancer	0.0192	0.0264	CbGbCtD
Carbamazepine—CYP2C9—Fluorouracil—skin cancer	0.0173	0.0237	CbGbCtD
Carbamazepine—ABCB1—Docetaxel—skin cancer	0.0128	0.0176	CbGbCtD
Carbamazepine—RALBP1—RalA downstream regulated genes—EXOC2—skin cancer	0.00929	0.302	CbGpPWpGaD
Carbamazepine—CYP3A4—Docetaxel—skin cancer	0.0077	0.0105	CbGbCtD
Carbamazepine—RALBP1—Rho GTPase cycle—RHOU—skin cancer	0.0026	0.0845	CbGpPWpGaD
Carbamazepine—SCN9A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00229	0.0745	CbGpPWpGaD
Carbamazepine—SCN4A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.0021	0.0685	CbGpPWpGaD
Carbamazepine—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00143	0.0464	CbGpPWpGaD
Carbamazepine—RALBP1—RalA downstream regulated genes—NRAS—skin cancer	0.0011	0.0359	CbGpPWpGaD
Carbamazepine—RALBP1—RalA downstream regulated genes—KRAS—skin cancer	0.000949	0.0309	CbGpPWpGaD
Carbamazepine—SCN9A—L1CAM interactions—SCN10A—skin cancer	0.000879	0.0286	CbGpPWpGaD
Carbamazepine—SCN4A—L1CAM interactions—SCN10A—skin cancer	0.000808	0.0263	CbGpPWpGaD
Carbamazepine—RALBP1—RalA downstream regulated genes—HRAS—skin cancer	0.000806	0.0262	CbGpPWpGaD
Carbamazepine—Nepafenac—PTGS2—skin cancer	0.000622	0.275	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—skin cancer	0.000608	0.269	CrCbGaD
Carbamazepine—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.000548	0.0178	CbGpPWpGaD
Carbamazepine—Oxaprozin—PTGS2—skin cancer	0.000517	0.228	CrCbGaD
Carbamazepine—Salsalate—PTGS2—skin cancer	0.000517	0.228	CrCbGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—RASA1—skin cancer	0.000504	0.0164	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—FOXO4—skin cancer	0.000413	0.0135	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—SCN10A—skin cancer	0.000332	0.0108	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—SCN10A—skin cancer	0.000305	0.00994	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—RHOU—skin cancer	0.000275	0.00894	CbGpPWpGaD
Carbamazepine—Rhinitis—Fluorouracil—skin cancer	0.000271	0.00114	CcSEcCtD
Carbamazepine—Dizziness—Vemurafenib—skin cancer	0.000269	0.00114	CcSEcCtD
Carbamazepine—Pharyngitis—Fluorouracil—skin cancer	0.000268	0.00113	CcSEcCtD
Carbamazepine—Angiopathy—Temozolomide—skin cancer	0.000266	0.00112	CcSEcCtD
Carbamazepine—Ataxia—Docetaxel—skin cancer	0.000265	0.00112	CcSEcCtD
Carbamazepine—Immune system disorder—Temozolomide—skin cancer	0.000265	0.00112	CcSEcCtD
Carbamazepine—Mediastinal disorder—Temozolomide—skin cancer	0.000264	0.00111	CcSEcCtD
Carbamazepine—Chills—Temozolomide—skin cancer	0.000263	0.00111	CcSEcCtD
Carbamazepine—Anaemia—Dactinomycin—skin cancer	0.000261	0.0011	CcSEcCtD
Carbamazepine—Liver function test abnormal—Docetaxel—skin cancer	0.00026	0.0011	CcSEcCtD
Carbamazepine—Vomiting—Vemurafenib—skin cancer	0.000259	0.00109	CcSEcCtD
Carbamazepine—Alopecia—Temozolomide—skin cancer	0.000259	0.00109	CcSEcCtD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000258	0.00838	CbGpPWpGaD
Carbamazepine—Chest pain—Bleomycin—skin cancer	0.000257	0.00108	CcSEcCtD
Carbamazepine—Myalgia—Bleomycin—skin cancer	0.000257	0.00108	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Docetaxel—skin cancer	0.000257	0.00108	CcSEcCtD
Carbamazepine—Rash—Vemurafenib—skin cancer	0.000257	0.00108	CcSEcCtD
Carbamazepine—Mental disorder—Temozolomide—skin cancer	0.000257	0.00108	CcSEcCtD
Carbamazepine—Dermatitis—Vemurafenib—skin cancer	0.000257	0.00108	CcSEcCtD
Carbamazepine—Hypersensitivity—Imiquimod—skin cancer	0.000256	0.00108	CcSEcCtD
Carbamazepine—Headache—Vemurafenib—skin cancer	0.000255	0.00108	CcSEcCtD
Carbamazepine—Erythema—Temozolomide—skin cancer	0.000255	0.00107	CcSEcCtD
Carbamazepine—Malnutrition—Temozolomide—skin cancer	0.000255	0.00107	CcSEcCtD
Carbamazepine—Cramp muscle—Docetaxel—skin cancer	0.000254	0.00107	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000254	0.00107	CcSEcCtD
Carbamazepine—Leukopenia—Dactinomycin—skin cancer	0.000252	0.00106	CcSEcCtD
Carbamazepine—Dysgeusia—Temozolomide—skin cancer	0.00025	0.00105	CcSEcCtD
Carbamazepine—Asthenia—Imiquimod—skin cancer	0.000249	0.00105	CcSEcCtD
Carbamazepine—Confusional state—Bleomycin—skin cancer	0.000249	0.00105	CcSEcCtD
Carbamazepine—Anaphylactic shock—Bleomycin—skin cancer	0.000247	0.00104	CcSEcCtD
Carbamazepine—Oedema—Bleomycin—skin cancer	0.000247	0.00104	CcSEcCtD
Carbamazepine—Back pain—Temozolomide—skin cancer	0.000247	0.00104	CcSEcCtD
Carbamazepine—Pruritus—Imiquimod—skin cancer	0.000246	0.00104	CcSEcCtD
Carbamazepine—Infection—Bleomycin—skin cancer	0.000245	0.00103	CcSEcCtD
Carbamazepine—Dysphagia—Docetaxel—skin cancer	0.000243	0.00103	CcSEcCtD
Carbamazepine—Nausea—Vemurafenib—skin cancer	0.000242	0.00102	CcSEcCtD
Carbamazepine—Thrombocytopenia—Bleomycin—skin cancer	0.000242	0.00102	CcSEcCtD
Carbamazepine—Arrhythmia—Fluorouracil—skin cancer	0.000241	0.00102	CcSEcCtD
Carbamazepine—Vision blurred—Temozolomide—skin cancer	0.00024	0.00101	CcSEcCtD
Carbamazepine—Myalgia—Dactinomycin—skin cancer	0.00024	0.00101	CcSEcCtD
Carbamazepine—Tremor—Temozolomide—skin cancer	0.000239	0.00101	CcSEcCtD
Carbamazepine—Alopecia—Fluorouracil—skin cancer	0.000238	0.00101	CcSEcCtD
Carbamazepine—Diarrhoea—Imiquimod—skin cancer	0.000238	0.001	CcSEcCtD
Carbamazepine—SCN9A—Developmental Biology—SCN10A—skin cancer	0.000237	0.00772	CbGpPWpGaD
Carbamazepine—Anaemia—Temozolomide—skin cancer	0.000236	0.000993	CcSEcCtD
Carbamazepine—Anorexia—Bleomycin—skin cancer	0.000235	0.000991	CcSEcCtD
Carbamazepine—Erythema—Fluorouracil—skin cancer	0.000235	0.00099	CcSEcCtD
Carbamazepine—Agitation—Temozolomide—skin cancer	0.000234	0.000988	CcSEcCtD
Carbamazepine—Angioedema—Temozolomide—skin cancer	0.000233	0.000982	CcSEcCtD
Carbamazepine—Pancytopenia—Docetaxel—skin cancer	0.000231	0.000974	CcSEcCtD
Carbamazepine—Hypotension—Bleomycin—skin cancer	0.000231	0.000972	CcSEcCtD
Carbamazepine—Oedema—Dactinomycin—skin cancer	0.00023	0.00097	CcSEcCtD
Carbamazepine—Dizziness—Imiquimod—skin cancer	0.00023	0.000968	CcSEcCtD
Carbamazepine—Vertigo—Temozolomide—skin cancer	0.000229	0.000966	CcSEcCtD
Carbamazepine—Infection—Dactinomycin—skin cancer	0.000229	0.000964	CcSEcCtD
Carbamazepine—Leukopenia—Temozolomide—skin cancer	0.000228	0.000962	CcSEcCtD
Carbamazepine—Thrombocytopenia—Dactinomycin—skin cancer	0.000225	0.00095	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000225	0.000947	CcSEcCtD
Carbamazepine—Paraesthesia—Bleomycin—skin cancer	0.000222	0.000934	CcSEcCtD
Carbamazepine—Weight increased—Docetaxel—skin cancer	0.000221	0.000934	CcSEcCtD
Carbamazepine—Vision blurred—Fluorouracil—skin cancer	0.000221	0.000933	CcSEcCtD
Carbamazepine—Convulsion—Temozolomide—skin cancer	0.000221	0.000931	CcSEcCtD
Carbamazepine—Vomiting—Imiquimod—skin cancer	0.000221	0.000931	CcSEcCtD
Carbamazepine—Hypertension—Temozolomide—skin cancer	0.00022	0.000928	CcSEcCtD
Carbamazepine—Dyspnoea—Bleomycin—skin cancer	0.00022	0.000927	CcSEcCtD
Carbamazepine—Anorexia—Dactinomycin—skin cancer	0.000219	0.000925	CcSEcCtD
Carbamazepine—Rash—Imiquimod—skin cancer	0.000219	0.000923	CcSEcCtD
Carbamazepine—Dermatitis—Imiquimod—skin cancer	0.000219	0.000922	CcSEcCtD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—BRAF—skin cancer	0.000219	0.00712	CbGpPWpGaD
Carbamazepine—Pneumonia—Docetaxel—skin cancer	0.000218	0.00092	CcSEcCtD
Carbamazepine—SCN4A—Developmental Biology—SCN10A—skin cancer	0.000218	0.00709	CbGpPWpGaD
Carbamazepine—Headache—Imiquimod—skin cancer	0.000218	0.000917	CcSEcCtD
Carbamazepine—Anaemia—Fluorouracil—skin cancer	0.000217	0.000915	CcSEcCtD
Carbamazepine—Arthralgia—Temozolomide—skin cancer	0.000217	0.000915	CcSEcCtD
Carbamazepine—Myalgia—Temozolomide—skin cancer	0.000217	0.000915	CcSEcCtD
Carbamazepine—Infestation NOS—Docetaxel—skin cancer	0.000217	0.000915	CcSEcCtD
Carbamazepine—Infestation—Docetaxel—skin cancer	0.000217	0.000915	CcSEcCtD
Carbamazepine—Anxiety—Temozolomide—skin cancer	0.000216	0.000912	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000216	0.000909	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000215	0.000907	CcSEcCtD
Carbamazepine—Decreased appetite—Bleomycin—skin cancer	0.000214	0.000904	CcSEcCtD
Carbamazepine—Renal failure—Docetaxel—skin cancer	0.000213	0.000899	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Docetaxel—skin cancer	0.000213	0.000897	CcSEcCtD
Carbamazepine—Dry mouth—Temozolomide—skin cancer	0.000212	0.000895	CcSEcCtD
Carbamazepine—Stomatitis—Docetaxel—skin cancer	0.000212	0.000892	CcSEcCtD
Carbamazepine—Jaundice—Docetaxel—skin cancer	0.000212	0.000892	CcSEcCtD
Carbamazepine—Pain—Bleomycin—skin cancer	0.000211	0.000889	CcSEcCtD
Carbamazepine—Conjunctivitis—Docetaxel—skin cancer	0.000211	0.000889	CcSEcCtD
Carbamazepine—Leukopenia—Fluorouracil—skin cancer	0.00021	0.000887	CcSEcCtD
Carbamazepine—Confusional state—Temozolomide—skin cancer	0.00021	0.000885	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00021	0.000884	CcSEcCtD
Carbamazepine—Oedema—Temozolomide—skin cancer	0.000208	0.000877	CcSEcCtD
Carbamazepine—Anaphylactic shock—Temozolomide—skin cancer	0.000208	0.000877	CcSEcCtD
Carbamazepine—SCN5A—Axon guidance—SCN10A—skin cancer	0.000207	0.00674	CbGpPWpGaD
Carbamazepine—Infection—Temozolomide—skin cancer	0.000207	0.000872	CcSEcCtD
Carbamazepine—Nausea—Imiquimod—skin cancer	0.000206	0.00087	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Docetaxel—skin cancer	0.000205	0.000865	CcSEcCtD
Carbamazepine—Nervous system disorder—Temozolomide—skin cancer	0.000204	0.00086	CcSEcCtD
Carbamazepine—Thrombocytopenia—Temozolomide—skin cancer	0.000204	0.000859	CcSEcCtD
Carbamazepine—Convulsion—Fluorouracil—skin cancer	0.000204	0.000858	CcSEcCtD
Carbamazepine—Feeling abnormal—Bleomycin—skin cancer	0.000203	0.000857	CcSEcCtD
Carbamazepine—Agranulocytosis—Docetaxel—skin cancer	0.000202	0.000854	CcSEcCtD
Carbamazepine—Skin disorder—Temozolomide—skin cancer	0.000202	0.000852	CcSEcCtD
Carbamazepine—Hyperhidrosis—Temozolomide—skin cancer	0.000201	0.000848	CcSEcCtD
Carbamazepine—Chest pain—Fluorouracil—skin cancer	0.0002	0.000843	CcSEcCtD
Carbamazepine—Myalgia—Fluorouracil—skin cancer	0.0002	0.000843	CcSEcCtD
Carbamazepine—Decreased appetite—Dactinomycin—skin cancer	0.0002	0.000843	CcSEcCtD
Carbamazepine—Fatigue—Dactinomycin—skin cancer	0.000198	0.000836	CcSEcCtD
Carbamazepine—Anorexia—Temozolomide—skin cancer	0.000198	0.000836	CcSEcCtD
Carbamazepine—Pain—Dactinomycin—skin cancer	0.000197	0.000829	CcSEcCtD
Carbamazepine—Urticaria—Bleomycin—skin cancer	0.000196	0.000826	CcSEcCtD
Carbamazepine—Rhinitis—Docetaxel—skin cancer	0.000195	0.000823	CcSEcCtD
Carbamazepine—Body temperature increased—Bleomycin—skin cancer	0.000195	0.000822	CcSEcCtD
Carbamazepine—Hepatitis—Docetaxel—skin cancer	0.000195	0.000821	CcSEcCtD
Carbamazepine—Confusional state—Fluorouracil—skin cancer	0.000193	0.000815	CcSEcCtD
Carbamazepine—Pharyngitis—Docetaxel—skin cancer	0.000193	0.000815	CcSEcCtD
Carbamazepine—Urinary tract disorder—Docetaxel—skin cancer	0.000192	0.000811	CcSEcCtD
Carbamazepine—Oedema peripheral—Docetaxel—skin cancer	0.000192	0.000809	CcSEcCtD
Carbamazepine—Oedema—Fluorouracil—skin cancer	0.000192	0.000808	CcSEcCtD
Carbamazepine—Anaphylactic shock—Fluorouracil—skin cancer	0.000192	0.000808	CcSEcCtD
Carbamazepine—Connective tissue disorder—Docetaxel—skin cancer	0.000191	0.000807	CcSEcCtD
Carbamazepine—Urethral disorder—Docetaxel—skin cancer	0.000191	0.000805	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—RASA1—skin cancer	0.000191	0.00621	CbGpPWpGaD
Carbamazepine—Infection—Fluorouracil—skin cancer	0.00019	0.000803	CcSEcCtD
Carbamazepine—Feeling abnormal—Dactinomycin—skin cancer	0.00019	0.000799	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00019	0.000799	CcSEcCtD
Carbamazepine—Insomnia—Temozolomide—skin cancer	0.000188	0.000793	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000188	0.000793	CcSEcCtD
Carbamazepine—Nervous system disorder—Fluorouracil—skin cancer	0.000188	0.000793	CcSEcCtD
Carbamazepine—Thrombocytopenia—Fluorouracil—skin cancer	0.000188	0.000791	CcSEcCtD
Carbamazepine—Tachycardia—Fluorouracil—skin cancer	0.000187	0.000789	CcSEcCtD
Carbamazepine—Paraesthesia—Temozolomide—skin cancer	0.000187	0.000788	CcSEcCtD
Carbamazepine—Dyspnoea—Temozolomide—skin cancer	0.000186	0.000782	CcSEcCtD
Carbamazepine—Somnolence—Temozolomide—skin cancer	0.000185	0.00078	CcSEcCtD
Carbamazepine—Erythema multiforme—Docetaxel—skin cancer	0.000184	0.000776	CcSEcCtD
Carbamazepine—Dyspepsia—Temozolomide—skin cancer	0.000183	0.000772	CcSEcCtD
Carbamazepine—Anorexia—Fluorouracil—skin cancer	0.000183	0.00077	CcSEcCtD
Carbamazepine—Eye disorder—Docetaxel—skin cancer	0.000182	0.000767	CcSEcCtD
Carbamazepine—Abdominal pain—Dactinomycin—skin cancer	0.000182	0.000767	CcSEcCtD
Carbamazepine—Body temperature increased—Dactinomycin—skin cancer	0.000182	0.000767	CcSEcCtD
Carbamazepine—Hypersensitivity—Bleomycin—skin cancer	0.000182	0.000766	CcSEcCtD
Carbamazepine—Decreased appetite—Temozolomide—skin cancer	0.000181	0.000763	CcSEcCtD
Carbamazepine—Flushing—Docetaxel—skin cancer	0.000181	0.000762	CcSEcCtD
Carbamazepine—Cardiac disorder—Docetaxel—skin cancer	0.000181	0.000762	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00018	0.000757	CcSEcCtD
Carbamazepine—Fatigue—Temozolomide—skin cancer	0.000179	0.000756	CcSEcCtD
Carbamazepine—Hypotension—Fluorouracil—skin cancer	0.000179	0.000755	CcSEcCtD
Carbamazepine—Pain—Temozolomide—skin cancer	0.000178	0.00075	CcSEcCtD
Carbamazepine—Constipation—Temozolomide—skin cancer	0.000178	0.00075	CcSEcCtD
Carbamazepine—Asthenia—Bleomycin—skin cancer	0.000177	0.000746	CcSEcCtD
Carbamazepine—Angiopathy—Docetaxel—skin cancer	0.000177	0.000745	CcSEcCtD
Carbamazepine—Immune system disorder—Docetaxel—skin cancer	0.000176	0.000742	CcSEcCtD
Carbamazepine—Mediastinal disorder—Docetaxel—skin cancer	0.000176	0.00074	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—RASA1—skin cancer	0.000175	0.00571	CbGpPWpGaD
Carbamazepine—Chills—Docetaxel—skin cancer	0.000175	0.000737	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000175	0.000736	CcSEcCtD
Carbamazepine—Pruritus—Bleomycin—skin cancer	0.000175	0.000736	CcSEcCtD
Carbamazepine—Arrhythmia—Docetaxel—skin cancer	0.000174	0.000734	CcSEcCtD
Carbamazepine—Insomnia—Fluorouracil—skin cancer	0.000173	0.000731	CcSEcCtD
Carbamazepine—Paraesthesia—Fluorouracil—skin cancer	0.000172	0.000726	CcSEcCtD
Carbamazepine—Alopecia—Docetaxel—skin cancer	0.000172	0.000726	CcSEcCtD
Carbamazepine—Feeling abnormal—Temozolomide—skin cancer	0.000171	0.000723	CcSEcCtD
Carbamazepine—Dyspnoea—Fluorouracil—skin cancer	0.000171	0.000721	CcSEcCtD
Carbamazepine—Mental disorder—Docetaxel—skin cancer	0.000171	0.000719	CcSEcCtD
Carbamazepine—Somnolence—Fluorouracil—skin cancer	0.00017	0.000719	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Temozolomide—skin cancer	0.00017	0.000717	CcSEcCtD
Carbamazepine—Erythema—Docetaxel—skin cancer	0.00017	0.000715	CcSEcCtD
Carbamazepine—Malnutrition—Docetaxel—skin cancer	0.00017	0.000715	CcSEcCtD
Carbamazepine—Hypersensitivity—Dactinomycin—skin cancer	0.00017	0.000715	CcSEcCtD
Carbamazepine—Dyspepsia—Fluorouracil—skin cancer	0.000169	0.000711	CcSEcCtD
Carbamazepine—Decreased appetite—Fluorouracil—skin cancer	0.000167	0.000703	CcSEcCtD
Carbamazepine—Dysgeusia—Docetaxel—skin cancer	0.000166	0.0007	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000166	0.000698	CcSEcCtD
Carbamazepine—Urticaria—Temozolomide—skin cancer	0.000165	0.000697	CcSEcCtD
Carbamazepine—Asthenia—Dactinomycin—skin cancer	0.000165	0.000696	CcSEcCtD
Carbamazepine—Abdominal pain—Temozolomide—skin cancer	0.000165	0.000693	CcSEcCtD
Carbamazepine—Body temperature increased—Temozolomide—skin cancer	0.000165	0.000693	CcSEcCtD
Carbamazepine—Back pain—Docetaxel—skin cancer	0.000164	0.000691	CcSEcCtD
Carbamazepine—Pain—Fluorouracil—skin cancer	0.000164	0.000691	CcSEcCtD
Carbamazepine—Muscle spasms—Docetaxel—skin cancer	0.000163	0.000687	CcSEcCtD
Carbamazepine—Feeling abnormal—Fluorouracil—skin cancer	0.000158	0.000666	CcSEcCtD
Carbamazepine—Diarrhoea—Dactinomycin—skin cancer	0.000157	0.000664	CcSEcCtD
Carbamazepine—Vomiting—Bleomycin—skin cancer	0.000157	0.000661	CcSEcCtD
Carbamazepine—Anaemia—Docetaxel—skin cancer	0.000157	0.000661	CcSEcCtD
Carbamazepine—Rash—Bleomycin—skin cancer	0.000156	0.000656	CcSEcCtD
Carbamazepine—Dermatitis—Bleomycin—skin cancer	0.000155	0.000655	CcSEcCtD
Carbamazepine—Hypersensitivity—Temozolomide—skin cancer	0.000153	0.000646	CcSEcCtD
Carbamazepine—Urticaria—Fluorouracil—skin cancer	0.000152	0.000642	CcSEcCtD
Carbamazepine—Syncope—Docetaxel—skin cancer	0.000152	0.000641	CcSEcCtD
Carbamazepine—Leukopenia—Docetaxel—skin cancer	0.000152	0.00064	CcSEcCtD
Carbamazepine—Body temperature increased—Fluorouracil—skin cancer	0.000152	0.000639	CcSEcCtD
Carbamazepine—Asthenia—Temozolomide—skin cancer	0.000149	0.000629	CcSEcCtD
Carbamazepine—Loss of consciousness—Docetaxel—skin cancer	0.000149	0.000628	CcSEcCtD
Carbamazepine—SCN5A—Developmental Biology—SCN10A—skin cancer	0.000148	0.00481	CbGpPWpGaD
Carbamazepine—Pruritus—Temozolomide—skin cancer	0.000147	0.000621	CcSEcCtD
Carbamazepine—Convulsion—Docetaxel—skin cancer	0.000147	0.000619	CcSEcCtD
Carbamazepine—Nausea—Bleomycin—skin cancer	0.000147	0.000618	CcSEcCtD
Carbamazepine—Hypertension—Docetaxel—skin cancer	0.000146	0.000617	CcSEcCtD
Carbamazepine—Vomiting—Dactinomycin—skin cancer	0.000146	0.000617	CcSEcCtD
Carbamazepine—Rash—Dactinomycin—skin cancer	0.000145	0.000612	CcSEcCtD
Carbamazepine—Chest pain—Docetaxel—skin cancer	0.000144	0.000609	CcSEcCtD
Carbamazepine—Arthralgia—Docetaxel—skin cancer	0.000144	0.000609	CcSEcCtD
Carbamazepine—Myalgia—Docetaxel—skin cancer	0.000144	0.000609	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000143	0.000604	CcSEcCtD
Carbamazepine—Diarrhoea—Temozolomide—skin cancer	0.000142	0.0006	CcSEcCtD
Carbamazepine—Hypersensitivity—Fluorouracil—skin cancer	0.000141	0.000596	CcSEcCtD
Carbamazepine—Dry mouth—Docetaxel—skin cancer	0.000141	0.000595	CcSEcCtD
Carbamazepine—Confusional state—Docetaxel—skin cancer	0.00014	0.000588	CcSEcCtD
Carbamazepine—Oedema—Docetaxel—skin cancer	0.000138	0.000583	CcSEcCtD
Carbamazepine—Anaphylactic shock—Docetaxel—skin cancer	0.000138	0.000583	CcSEcCtD
Carbamazepine—Dizziness—Temozolomide—skin cancer	0.000138	0.00058	CcSEcCtD
Carbamazepine—Infection—Docetaxel—skin cancer	0.000137	0.00058	CcSEcCtD
Carbamazepine—Nausea—Dactinomycin—skin cancer	0.000137	0.000576	CcSEcCtD
Carbamazepine—Shock—Docetaxel—skin cancer	0.000136	0.000574	CcSEcCtD
Carbamazepine—SCN9A—Developmental Biology—RASA1—skin cancer	0.000136	0.00443	CbGpPWpGaD
Carbamazepine—Nervous system disorder—Docetaxel—skin cancer	0.000136	0.000572	CcSEcCtD
Carbamazepine—Pruritus—Fluorouracil—skin cancer	0.000136	0.000572	CcSEcCtD
Carbamazepine—Thrombocytopenia—Docetaxel—skin cancer	0.000136	0.000571	CcSEcCtD
Carbamazepine—Tachycardia—Docetaxel—skin cancer	0.000135	0.000569	CcSEcCtD
Carbamazepine—Skin disorder—Docetaxel—skin cancer	0.000134	0.000567	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—PTCH2—skin cancer	0.000134	0.00437	CbGpPWpGaD
Carbamazepine—Vomiting—Temozolomide—skin cancer	0.000132	0.000558	CcSEcCtD
Carbamazepine—Anorexia—Docetaxel—skin cancer	0.000132	0.000556	CcSEcCtD
Carbamazepine—Rash—Temozolomide—skin cancer	0.000131	0.000553	CcSEcCtD
Carbamazepine—Diarrhoea—Fluorouracil—skin cancer	0.000131	0.000553	CcSEcCtD
Carbamazepine—Dermatitis—Temozolomide—skin cancer	0.000131	0.000553	CcSEcCtD
Carbamazepine—Headache—Temozolomide—skin cancer	0.00013	0.00055	CcSEcCtD
Carbamazepine—Hypotension—Docetaxel—skin cancer	0.000129	0.000545	CcSEcCtD
Carbamazepine—Dizziness—Fluorouracil—skin cancer	0.000127	0.000534	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000126	0.000532	CcSEcCtD
Carbamazepine—Insomnia—Docetaxel—skin cancer	0.000125	0.000528	CcSEcCtD
Carbamazepine—SCN4A—Developmental Biology—RASA1—skin cancer	0.000125	0.00407	CbGpPWpGaD
Carbamazepine—Paraesthesia—Docetaxel—skin cancer	0.000124	0.000524	CcSEcCtD
Carbamazepine—Nausea—Temozolomide—skin cancer	0.000124	0.000521	CcSEcCtD
Carbamazepine—Dyspnoea—Docetaxel—skin cancer	0.000123	0.00052	CcSEcCtD
Carbamazepine—Somnolence—Docetaxel—skin cancer	0.000123	0.000519	CcSEcCtD
Carbamazepine—Vomiting—Fluorouracil—skin cancer	0.000122	0.000514	CcSEcCtD
Carbamazepine—Dyspepsia—Docetaxel—skin cancer	0.000122	0.000514	CcSEcCtD
Carbamazepine—Rash—Fluorouracil—skin cancer	0.000121	0.00051	CcSEcCtD
Carbamazepine—Dermatitis—Fluorouracil—skin cancer	0.000121	0.000509	CcSEcCtD
Carbamazepine—Decreased appetite—Docetaxel—skin cancer	0.00012	0.000507	CcSEcCtD
Carbamazepine—Headache—Fluorouracil—skin cancer	0.00012	0.000506	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000119	0.000504	CcSEcCtD
Carbamazepine—Fatigue—Docetaxel—skin cancer	0.000119	0.000503	CcSEcCtD
Carbamazepine—SCN5A—Axon guidance—RASA1—skin cancer	0.000119	0.00387	CbGpPWpGaD
Carbamazepine—Pain—Docetaxel—skin cancer	0.000118	0.000499	CcSEcCtD
Carbamazepine—Constipation—Docetaxel—skin cancer	0.000118	0.000499	CcSEcCtD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—KRAS—skin cancer	0.000118	0.00385	CbGpPWpGaD
Carbamazepine—Feeling abnormal—Docetaxel—skin cancer	0.000114	0.000481	CcSEcCtD
Carbamazepine—Nausea—Fluorouracil—skin cancer	0.000114	0.00048	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Docetaxel—skin cancer	0.000113	0.000477	CcSEcCtD
Carbamazepine—Abdominal pain—Docetaxel—skin cancer	0.000109	0.000461	CcSEcCtD
Carbamazepine—Body temperature increased—Docetaxel—skin cancer	0.000109	0.000461	CcSEcCtD
Carbamazepine—Hypersensitivity—Docetaxel—skin cancer	0.000102	0.00043	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—GLI2—skin cancer	0.000102	0.00331	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—skin cancer	0.000101	0.00327	CbGpPWpGaD
Carbamazepine—Asthenia—Docetaxel—skin cancer	9.93e-05	0.000419	CcSEcCtD
Carbamazepine—Pruritus—Docetaxel—skin cancer	9.79e-05	0.000413	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—MC1R—skin cancer	9.7e-05	0.00316	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—GLI1—skin cancer	9.56e-05	0.00311	CbGpPWpGaD
Carbamazepine—Diarrhoea—Docetaxel—skin cancer	9.47e-05	0.000399	CcSEcCtD
Carbamazepine—Dizziness—Docetaxel—skin cancer	9.15e-05	0.000386	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—SUFU—skin cancer	9.06e-05	0.00295	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	8.81e-05	0.00287	CbGpPWpGaD
Carbamazepine—Vomiting—Docetaxel—skin cancer	8.8e-05	0.000371	CcSEcCtD
Carbamazepine—Rash—Docetaxel—skin cancer	8.73e-05	0.000368	CcSEcCtD
Carbamazepine—Dermatitis—Docetaxel—skin cancer	8.72e-05	0.000367	CcSEcCtD
Carbamazepine—Headache—Docetaxel—skin cancer	8.67e-05	0.000365	CcSEcCtD
Carbamazepine—SCN5A—Developmental Biology—RASA1—skin cancer	8.48e-05	0.00276	CbGpPWpGaD
Carbamazepine—Nausea—Docetaxel—skin cancer	8.22e-05	0.000347	CcSEcCtD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	7.69e-05	0.0025	CbGpPWpGaD
Carbamazepine—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	7.05e-05	0.00229	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SHH—skin cancer	6.91e-05	0.00225	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—RASA1—skin cancer	6.87e-05	0.00224	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CDK4—skin cancer	6.68e-05	0.00217	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PTCH1—skin cancer	6.55e-05	0.00213	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SMO—skin cancer	6.55e-05	0.00213	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PTGER4—skin cancer	6.38e-05	0.00208	CbGpPWpGaD
Carbamazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	6.29e-05	0.00205	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CDK4—skin cancer	6.14e-05	0.002	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	6.03e-05	0.00196	CbGpPWpGaD
Carbamazepine—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	5.73e-05	0.00187	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	5.72e-05	0.00186	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—FOXO4—skin cancer	5.63e-05	0.00183	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PLIN2—skin cancer	5.49e-05	0.00179	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.28e-05	0.00172	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	5.24e-05	0.00171	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—NRAS—skin cancer	5.2e-05	0.00169	CbGpPWpGaD
Carbamazepine—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	4.9e-05	0.0016	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—NRAS—skin cancer	4.78e-05	0.00156	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.71e-05	0.00153	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—KRAS—skin cancer	4.48e-05	0.00146	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CSPG4—skin cancer	4.43e-05	0.00144	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.29e-05	0.0014	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CDK4—skin cancer	4.16e-05	0.00135	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.14e-05	0.00135	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—KRAS—skin cancer	4.11e-05	0.00134	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	4.08e-05	0.00133	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	4.07e-05	0.00133	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—HRAS—skin cancer	3.81e-05	0.00124	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TERT—skin cancer	3.76e-05	0.00122	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PLIN2—skin cancer	3.75e-05	0.00122	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—NRAS—skin cancer	3.71e-05	0.00121	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.67e-05	0.00119	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—IL6—skin cancer	3.64e-05	0.00119	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	3.51e-05	0.00114	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—HRAS—skin cancer	3.5e-05	0.00114	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—NRAS—skin cancer	3.41e-05	0.00111	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—IL6—skin cancer	3.35e-05	0.00109	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—NRAS—skin cancer	3.24e-05	0.00105	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—KRAS—skin cancer	3.2e-05	0.00104	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CSPG4—skin cancer	3.03e-05	0.000985	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ENO2—skin cancer	3.01e-05	0.00098	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.98e-05	0.000971	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—BRAF—skin cancer	2.98e-05	0.00097	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.94e-05	0.000957	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—KRAS—skin cancer	2.94e-05	0.000956	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—KRAS—skin cancer	2.79e-05	0.000908	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PLIN2—skin cancer	2.78e-05	0.000904	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—HRAS—skin cancer	2.72e-05	0.000884	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PLIN2—skin cancer	2.71e-05	0.000883	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—IL6—skin cancer	2.6e-05	0.000846	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—HRAS—skin cancer	2.5e-05	0.000812	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—IL6—skin cancer	2.39e-05	0.000778	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—HRAS—skin cancer	2.37e-05	0.000772	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PLIN2—skin cancer	2.35e-05	0.000765	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—NRAS—skin cancer	2.31e-05	0.000753	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—IL6—skin cancer	2.27e-05	0.000739	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CSPG4—skin cancer	2.24e-05	0.000728	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CSPG4—skin cancer	2.19e-05	0.000712	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.1e-05	0.000684	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PLIN2—skin cancer	2.1e-05	0.000683	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ENO2—skin cancer	2.06e-05	0.000669	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PLIN2—skin cancer	2.05e-05	0.000666	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—KRAS—skin cancer	1.99e-05	0.000648	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PLIN2—skin cancer	1.91e-05	0.000623	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CSPG4—skin cancer	1.89e-05	0.000617	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NRAS—skin cancer	1.87e-05	0.00061	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ERCC2—skin cancer	1.75e-05	0.000569	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HRAS—skin cancer	1.69e-05	0.000551	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CSPG4—skin cancer	1.69e-05	0.00055	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CSPG4—skin cancer	1.65e-05	0.000537	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PLIN2—skin cancer	1.63e-05	0.000532	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—IL6—skin cancer	1.62e-05	0.000527	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KRAS—skin cancer	1.61e-05	0.000525	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CSPG4—skin cancer	1.54e-05	0.000502	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ENO2—skin cancer	1.52e-05	0.000495	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ENO2—skin cancer	1.49e-05	0.000484	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—skin cancer	1.43e-05	0.000466	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.41e-05	0.000458	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—skin cancer	1.37e-05	0.000446	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CSPG4—skin cancer	1.32e-05	0.000429	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL6—skin cancer	1.31e-05	0.000427	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ENO2—skin cancer	1.29e-05	0.000419	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PLIN2—skin cancer	1.26e-05	0.000411	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.25e-05	0.000407	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ERCC2—skin cancer	1.19e-05	0.000389	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ENO2—skin cancer	1.15e-05	0.000374	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO2—skin cancer	1.12e-05	0.000365	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—skin cancer	1.05e-05	0.000341	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO2—skin cancer	1.05e-05	0.000341	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CSPG4—skin cancer	1.02e-05	0.000331	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.01e-05	0.000328	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.99e-06	0.000293	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—skin cancer	8.96e-06	0.000291	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ERCC2—skin cancer	8.83e-06	0.000288	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ERCC2—skin cancer	8.64e-06	0.000281	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.2e-06	0.000267	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ERCC2—skin cancer	7.48e-06	0.000243	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—skin cancer	7.16e-06	0.000233	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7e-06	0.000228	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—skin cancer	6.91e-06	0.000225	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ERCC2—skin cancer	6.68e-06	0.000217	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ERCC2—skin cancer	6.52e-06	0.000212	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ERCC2—skin cancer	6.09e-06	0.000198	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—skin cancer	5.3e-06	0.000172	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ERCC2—skin cancer	5.2e-06	0.000169	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—skin cancer	5.18e-06	0.000169	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—skin cancer	4.48e-06	0.000146	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ERCC2—skin cancer	4.01e-06	0.000131	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—skin cancer	4e-06	0.00013	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—skin cancer	3.91e-06	0.000127	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—skin cancer	3.65e-06	0.000119	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—skin cancer	3.12e-06	0.000102	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—skin cancer	2.41e-06	7.84e-05	CbGpPWpGaD
